Atlas Trials

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Clinical trial NCT04414540 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04414540
Sponsor
Trisha Wise-Draper
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2020-08-31
Primary completion
2026-02-02
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.